TrialBritish journal of clinical pharmacology2019

Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.

Matthew Sheetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.